Navigation Links
Cedars-Sinai Board of Governors to Honor Ryan Seacrest & John Bendheim at Annual 'Road To A Cure' Gala
Date:12/1/2008

LOS ANGELES, Dec. 1 /PRNewswire/ -- Media entrepreneur, television and radio host Ryan Seacrest and real estate investor and philanthropist John Bendheim will be honored by the Cedars-Sinai Board of Governors at their annual "Road To A Cure" Gala, December 2, 2008, at the Hyatt Regency Century Plaza hotel. Rick Powell, Chairman of the Board of Governors, co-chairs the event with Debbee Klein Schwartz, Aaron Kaplan and Fran Solomon. The "Road To A Cure" Gala is sponsored by Lexus, which has donated a 2009 Lexus LS 600h L hybrid luxury sedan for an opportunity drawing during the event. Oscar-winner Lionel Richie and David Archuleta will perform; Larry King will host.

Ben Silverman, Co-Chairman of NBC Entertainment and Universal Media Studios, will present the Heart of Hollywood Award to Ryan Seacrest, host and producer of multiple television and radio programs including American Idol, E! News, Dick Clark'sNew Year's Rockin' Eve with Ryan Seacrest, American Top 40 and LA's top-rated morning radio show 102.7 KIIS FM. Seacrest built Ryan Seacrest Productions (RSP) into a viable entity creating content for all media platforms. He can next be seen returning as host of the eighth season of Fox Television's #1 hit show, American Idol.

John Bendheim, president of Bendheim Enterprises, Inc., a real estate investment holding company, and founder of Inland Homes, will be honored with the Philanthropic Leadership Award. Bendheim's humanitarian endeavors have benefited a multitude of worthy causes including Cedars-Sinai Medical Center, where he sits on the Board of Directors. He is past Chair of the medical center's Board of Governors and has also served as Chairman of the Cedars- Sinai Sports Spectacular, which raises millions of dollars for the Medical Genetics Institute.

The "Road To A Cure" Gala benefits the newly established Board of Governors Heart Stem Cell Center at Cedars-Sinai. The Center's focus includes
'/>"/>

SOURCE Cedars-Sinai Medical Center
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Barbra Streisand endows program at Cedars-Sinai womens heart center
2. Cedars-Sinai Medical Center opens patient trial of virus that attacks brain cancer cells
3. PharmMD Expands Advisory Board
4. Mr. Tad Ballantyne to Join Mach One Board of Directors
5. BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases
6. Transdel Pharmaceuticals Appoints Mr. Lynn Swann, Pro-Football Hall of Famer, ABC Sports Broadcaster, and Former Chairman of the Presidents Council on Physical Fitness and Sports, to Board of Directors
7. Craig A. Norris Appointed to Providence Service Corporation Board of Directors
8. Investor Group Commends Clint Severson for Joining Trinity Biotechs Board of Directors
9. Savients Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase
10. MDS Inc. Announces Appointment of James S.A. MacDonald as Chairman of Board of Directors
11. Introducing The Hot Tooth Keyboard, the Cleanable, Hygienic, Wireless Keyboard for Dental Practitioners and Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2009)...SNewswire/ -- Pro-life forces won an important bat... uphold a state law regulating that abortion cente...ering RU-486 (also known as the "abortion pill") i...rug. , , The ruling came in Rogers v. Planned... a 2004 law requiring that those administering RU-...
(Date:7/2/2009)...sses honored in Washington, D.C. , , ARLINGTON... Health Resources has received the Best Employers...usiness Group on Health. , , (Logo: http://w... ) , , The award recognizes the nation,s leadi...te a healthy workplace and for helping employees a...
(Date:7/2/2009)...educe threat, expert says , , THURSDAY,...at to certain species of wildlife, which need to b... say. , "Cancer is one of the leading health co...cent of human deaths. But we now understand that c...d author Denise McAloose, chief pathologist for th...
(Date:7/2/2009)... set of neurons, another set wakes up: study , ... information about brain circuit activity may help...bien (zolpidem) walk, eat, talk on the phone and e...embering it the next morning. , The drug has al...ts into a conscious state. , In experiments wit...
Breaking Medicine News(10 mins):Health News:Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of 'Abortion Pill' 2Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 2Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 3Health News:Cancer Endangers Some Wildlife Species 2Health News:Odd Behaviors on Ambien Linked to Brain Circuitry 2
...er to carry out a stomach-stapling surgery by intr...ision. // Around 1 million bariatric surgeries ...ry is recommended for weight loss and it involves ...h, making it smaller, as a result, people eat less...
...ination of 3 HIV/AIDS drugs, Viraday that needs to... // The three anti-HIV drugs efavirenz 600 mg, te...e drug Viraday.Viraday, one tablet of which alone ...on, eliminates the need for 3 separate medicines. ...
... taking the death toll in the capital to 24, while...ealth officials launched a war against// the mosqu...he total number of patients in Delhi rose Friday t..."We have received 92 new patients since Thursday. ...
...type C (GBV-C) protects against HIV infection is n...t of Veterans Affairs (VA) Iowa// City Health Care... a protein segment that strongly inhibits HIV from...nd that an 85-amino acid segment within a GBV-C vi...
Other Medicine News:Health News:NOTE surgery – to combat obesit 2Health News:Delhi Death Toll Due to Dengue Rises to 24 2Health News:Study IDs Protein That Inhibits HIV From Growing In Cell Cultures 2Health News:Study IDs Protein That Inhibits HIV From Growing In Cell Cultures 3
(Date:7/2/2009)...ATINE, Ill. and BRISTOL, Tenn., July 2 /PRNewswire...: ACUR ) and King Pharmaceuticals, Inc. (NYSE: ...Administration (FDA) has issued a Complete Respons...for Acurox (oxycodone HC1, USP and niacin, USP) Ta...or the relief of moderate-to-severe pain. , ,...
(Date:6/30/2009)...LOTHIAN, Va., June 30 In two recen... nebulizer and PRONEB compressors (Ultra and Ultra...umarate (Perforomist, DEY LP, Mylan Inc.) improves...researchers chose PARI products as the exclusive n...tenance treatments for COPD. Sutherland et al. us...
(Date:6/29/2009)...spective Study Seeks to Assess RSV Burden in Outpa...ng Commitment to Pediatric Research , , GAITH...ntinues to advance its commitment to pediatric res...vational prospective study designed to assess the ...preterm infants 32-to-35 weeks gestational age (GA...
(Date:6/28/2009)...HMOND, Calif., June 29 S...nnounced that a key research milestone has been ac...Genentech, Inc., a wholly-owned member of the Roch...el characteristics for pharmaceutical protein prod...inger DNA-binding protein nuclease (ZFN) technolog...
Breaking Medicine Technology:Acura and King Receive FDA Complete Response Letter Regarding Acurox(R) 2Acura and King Receive FDA Complete Response Letter Regarding Acurox(R) 3PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies 2MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 2Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 2Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 3Nektar to Announce Financial Results for the Second Quarter of 2008 on Wednesday August 6 2008 After Close of U S Based Financial Markets 6836 1Nektar to Announce Financial Results for the Second Quarter of 2008 on Wednesday August 6 2008 After Close of U S Based Financial Markets 6836 2InterMune to Present at BMO Healthcare Conference 6834 1Bioheart Inc Announces Financial Results for Second Quarter 2008 6832 1Bioheart Inc Announces Financial Results for Second Quarter 2008 6832 2Bioheart Inc Announces Financial Results for Second Quarter 2008 6832 3Bioheart Inc Announces Financial Results for Second Quarter 2008 6832 4Bioheart Inc Announces Financial Results for Second Quarter 2008 6832 5Bioheart Inc Announces Financial Results for Second Quarter 2008 6832 6Bioheart Inc Announces Financial Results for Second Quarter 2008 6832 7Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 6830 1Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 6830 2Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 6830 3Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 6830 4Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 6830 5Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 6830 6Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 6830 7Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 6830 8Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 6830 9
..., 2007 /PRNewswire-FirstCall/ -- Vion,Pharmaceutic...a in,a poster session at the 12th Congress of the ...ienna, Austria on its lead anticancer,agent Cloret...center international Phase II clinical trial in a ...leukemia (AML) or high-risk,myelodysplastic syndro...
...ESS WIRE)--Jun 11, 2007 - Geron,Corporation (Nasda...ch studies indicating that GRNOPC1, the company,s ... for the treatment of,spinal cord injury, evades a...ted by Geron scientist Ross Okamura at the Federat...n Diego, the findings,could mean that patients tre...
Other Medicine Technology:Vion Pharmaceuticals Presents Clinical Data from a Phase II Trial,of Cloretazine (VNP40101M) in Elderly AML Patients with Unfavorable,Cytogenetics at EHA Meeting 2Vion Pharmaceuticals Presents Clinical Data from a Phase II Trial,of Cloretazine (VNP40101M) in Elderly AML Patients with Unfavorable,Cytogenetics at EHA Meeting 3Vion Pharmaceuticals Presents Clinical Data from a Phase II Trial,of Cloretazine (VNP40101M) in Elderly AML Patients with Unfavorable,Cytogenetics at EHA Meeting 4Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 2Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 3
...n the way it implements the confocal principle, th...It allows multi fluorescence images to be collecte...Unprecedented flexibility for individual applicati...ions that guarantee fast and efficient structural ...
...esigned for system expandability: the first invert...e the infinity space. Multi-port design enables op... variety of illumination and detector equipment. E...s the addition of an optional light source and oth...
...olor video camera with direct digital output. Thre... fluorescence applications. Olympus wide array of ...image quality and flexibility you need for an effi...ide a high-resolution, real-time image of your spe...
...he PM30 is a premium photomicrography system that...hs of even the most difficult specimens. Designed ...e solution to the complex problem of fluorescence ...xposure control, the system utilizes special progr...
Medicine Products: